MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

Newsletter

Newsletter

Monitoring Changes of Spontaneous Neuronal Activity in Response to Compound Treatment via Genetically-Encoded Calcium Indicator (GECI)
QPS Neuropharmacology
Spontaneous neuronal activity of cultivated cells is one of the physiologically most relevant read-outs related to neuronal health. Calcium concentration is widely used in neuroscience as a competent indirect reporter of neural activity, as action potential (AP) firing triggers large influxes of Ca2+ through voltage-gated calcium channels. Utilizing IncuCyte® NeuroBurst, a genetically-encoded calcium indicator (GECI), …
Read More
Measuring compound muscle action potentials in SOD1-G93A mice reveals pathological changes in this amyotrophic lateral sclerosis model
QPS Neuropharmacology
Compound muscle action potential (CMAP) is an electrophysiological technique commonly employed to monitor the functional status of muscles in anesthetized animals. CMAP measurements offer insight into physiological development as well as degeneration of the peripheral neuromuscular system. As part of the electromyographic (EMG) evaluation, CMAP is regularly used in diagnostic and clinical human studies, providing …
Read More
Fmr1-KO mice show increased levels of neuroinflammation and myelination in different parts of the brain
QPS Neuropharmacology
A mutation of the FMR1 gene (Fragile X mental retardation 1) leads to a X-linked genetic disorder called Fragile X syndrome (FXS), the most frequently inherited form of intellectual disability and the monogenic cause of autism spectrum disorder (ASD). Patients of ASD present communication and socialization impairments, repetitive behaviors with restricted interest, and hyperactivity. Silencing …
Read More
zQ175DN-KI Mice as Model of Huntington Disease
QPS Neuropharmacology
Huntington’s disease (HD) is an autosomal-dominantly inherited, fatal, neurodegenerative disorder. Patients present with motor dysfunctions, psychiatric symptoms, cognitive impairments, and metabolic abnormalities. HD is solely caused by the expansion of an unstable repeat of CAG base triplets in the coding region of the Huntingtin gene, HTT. The age of disease onset correlates inversely with the …
Read More
6neo mice closely mimic non-neuronal and neuronal pathology of Pompe disease
QPS Neuropharmacology
After validating muscle weakness and motor deficits in young 6neo mice as model of Pompe disease, our team now evaluated acid α-glucosidase (GAA) enzyme activity to validate enzyme reduction and glycogen substrate levels in non-neuronal and neuronal tissue of this lysosomal storage disease mouse model. Quadriceps femoris muscle and cortical tissue of Pompe 6neo mice …
Read More

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE